Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 2;23(5):315. doi: 10.3892/mmr.2021.11954

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Pak et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 3. — SP analysis following the treatment with C5E and/or gemcitabine. PANC-1 cells were treated with C5E and/or gemcitabine for 72 h. (A) Proportion of SP and non-SP cells was analyzed in the presence of Hoechst 33342 or Hoechst 33342 plus verapamil (an inhibitor of multidrug resistance protein) using a FACSAria flow cytometer. (B) Quantification of the SP in each treatment group form part (A). **P<0.01, ***P<0.001 vs. control (−) verapamil. SP, side population.